Systemic Immunity Is Required for Effective Cancer Immunotherapy-Reference-Cited by-同舟云学术

Systemic Immunity Is Required for Effective Cancer Immunotherapy

Published:2017-01 Issue:3 Volume:168 Page:487-502.e15
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Spitzer Matthew H.,Carmi Yaron,Reticker-Flynn Nathan E.,Kwek Serena S.,Madhireddy Deepthi,Martins Maria M.,Gherardini Pier Federico,Prestwood Tyler R.,Chabon Jonathan,Bendall Sean C.,Fong Lawrence,Nolan Garry P.,Engleman Edgar G.

Funder

NIH

DOD

Gates Foundation

NIAID

FDA

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference43 articles.

1. Semi-supervised methods to predict patient survival from gene expression data;Bair;PLoS Biol.,2004

2. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry;Bandura;Anal. Chem.,2009

3. Bastian, M., Heymann, S., and Jacomy, M. (2009). Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media. http://www.aaai.org/ocs/index.php/ICWSM/09/paper/view/154/1009.

4. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse;Bates;J. Clin. Oncol.,2006

5. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum;Bendall;Science,2011

Cited by 736 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11

2. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

3. Combined cryoablation and PD-1 inhibitor synergistically enhance antitumor immune responses in Lewis lung adenocarcinoma mice via the PI3K/AKT/mTOR pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

4. Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment;2024-09-10

5. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09